Literature DB >> 10595910

Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas.

A Rosenwald1, G Ott, S Stilgenbauer, J Kalla, M Bredt, T Katzenberger, A Greiner, M M Ott, B Gawin, H Döhner, H K Müller-Hermelink.   

Abstract

Extranodal mucosa-associated lymphoid tissue (MALT)-type lymphomas and nodal and splenic marginal zone B cell lymphomas (MZBL) share morphological and immunophenotypic features with marginal zone B cells of reactive lymphoid tissues. Although displaying a similar immunophenotype, recent investigations suggest fundamental genetic differences among these subgroups. To determine the prevalence of the t(11;18) in a larger series of MALT-type lymphomas and to investigate a possible occurrence in other lymphomas, we screened 106 non-Hodgkin's lymphomas (NHL) by interphase cytogenetics using yeast artificial chromosome (YAC) probes flanking the breakpoint at 11q21. A signal constellation indicating a disruption in 11q21 and thus pointing to the presence of the t(11;18) was observed in 9 of 33 (27%) low-grade lymphomas of MALT type. The complete absence of t(11;18)-positive cells in 32 primary and secondary extranodal high-grade lymphomas suggests that low-grade lymphomas of MALT type characterized by the t(11;18) are unlikely to transform into high-grade tumors. The absence of tumor cells carrying the t(11;18) in nodal MZBL challenges the assumption that most, if not all, of these tumors represent the nodal manifestation of a so far undetected low-grade lymphoma of MALT type. The t(11;18) was not detected in a single case of 29 splenic MZBL investigated. This observation strengthens the view that splenic MZBL are biologically different from extranodal MZBL of MALT type.

Entities:  

Mesh:

Year:  1999        PMID: 10595910      PMCID: PMC1866937          DOI: 10.1016/S0002-9440(10)65499-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.

Authors:  G Ott; T Katzenberger; A Greiner; J Kalla; A Rosenwald; U Heinrich; M M Ott; H K Müller-Hermelink
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

2.  Genetic evidence for a clonal link between low and high-grade components in gastric MALT B-cell lymphoma.

Authors:  H Peng; M Du; T C Diss; P G Isaacson; L Pan
Journal:  Histopathology       Date:  1997-05       Impact factor: 5.087

3.  Low grade gastric B-cell MALT lymphoma progressing into high grade lymphoma. Clonal identity of the two stages of the tumour, unusual bone involvement and leukemic dissemination.

Authors:  C Montalbán; A Manzanal; J M Castrillo; L Escribano; C Bellas
Journal:  Histopathology       Date:  1995-07       Impact factor: 5.087

4.  Detection of chromosomal aberrations by means of molecular cytogenetics: painting of chromosomes and chromosomal subregions and comparative genomic hybridization.

Authors:  P Lichter; M Bentz; S Joos
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  The histopathology of splenic lymphoma with villous lymphocytes.

Authors:  P G Isaacson; E Matutes; M Burke; D Catovsky
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

6.  Monocytoid B cells. A comparative clinical pathological study of their distribution in different types of low-grade lymphomas.

Authors:  M Mollejo; J Menárguez; E Cristóbal; P Algara; E Sánchez-Díaz; M Fraga; M A Piris
Journal:  Am J Surg Pathol       Date:  1994-11       Impact factor: 6.394

7.  Structural abnormalities of chromosome 7q in chronic lymphoproliferative disorders.

Authors:  D G Oscier; A Gardiner; S Mould
Journal:  Cancer Genet Cytogenet       Date:  1996-11

8.  Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.

Authors:  M Mollejo; J Menárguez; E Lloret; A Sánchez; E Campo; P Algara; E Cristóbal; E Sánchez; M A Piris
Journal:  Am J Surg Pathol       Date:  1995-10       Impact factor: 6.394

9.  Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features.

Authors:  J Dierlamm; S Pittaluga; I Wlodarska; M Stul; J Thomas; M Boogaerts; L Michaux; A Driessen; C Mecucci; J J Cassiman; C De Wolf-Peeters; H Van den Berghe
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

10.  Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria.

Authors:  J M Hernandez; C Mecucci; A Criel; P Meeus; I Michaux; A Van Hoof; G Verhoef; A Louwagie; J M Scheiff; J L Michaux
Journal:  Leukemia       Date:  1995-12       Impact factor: 11.528

View more
  14 in total

Review 1.  Molecular diagnostic approach to non-Hodgkin's lymphoma.

Authors:  D A Arber
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

2.  API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens.

Authors:  H Inagaki; M Okabe; M Seto; S Nakamura; R Ueda; T Eimoto
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 3.  Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.

Authors:  Kian-Huat Lim; Yibin Yang; Louis M Staudt
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 4.  Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.

Authors:  Chris M Bacon; Ming-Qing Du; Ahmet Dogan
Journal:  J Clin Pathol       Date:  2006-09-01       Impact factor: 3.411

5.  Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features.

Authors:  Hiroshi Inagaki; John K C Chan; Josephine W M Ng; Mitsukuni Okabe; Tadashi Yoshino; Masataka Okamoto; Hiroshi Ogawa; Hiroshi Matsushita; Tomoyuki Yokose; Yoshihiro Matsuno; Naoya Nakamura; Tetsuro Nagasaka; Ryuzo Ueda; Tadaaki Eimoto; Shigeo Nakamura
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Tumor-infiltrating T cells with similar antigen binding sites in different mucosa-associated lymphoid tissue type B cell lymphomas.

Authors:  Harald Seeberger; Constanze Knörr; Christian Mainhardt; Hans Konrad Müller-Hermelink; Axel Greiner
Journal:  Virchows Arch       Date:  2003-02-19       Impact factor: 4.064

7.  Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways.

Authors:  Ellen D Remstein; Paul J Kurtin; C David James; Xiao-Yang Wang; Reid G Meyer; Gordon W Dewald
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

Review 8.  Chromosomal translocation t(11;18)(q21;q21) in gastrointestinal mucosa associated lymphoid tissue lymphoma.

Authors:  S Nakamura; T Matsumoto; S Nakamura; Y Jo; K Fujisawa; H Suekane; T Yao; M Tsuneyoshi; M Iida
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

9.  18q21 Rearrangement and trisomy 3 in extranodal B-cell lymphomas: a study using a fluorescent in situ hybridisation technique.

Authors:  Yan-Chin Tai; Jin-Ai Mary Anne Tan; Suat-Cheng Peh
Journal:  Virchows Arch       Date:  2004-09-09       Impact factor: 4.064

10.  API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

Authors:  Mitsukuni Okabe; Hiroshi Inagaki; Koichi Ohshima; Tadashi Yoshino; Chunmei Li; Tadaaki Eimoto; Ryuzo Ueda; Shigeo Nakamura
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.